Genetic testing can be a genuinely useful tool, but whether it’s a good idea for you depends entirely on what you’re testing for, what type of test you use, and what you plan to do with the results. For some people, it provides lifesaving information that changes medical care. For others, it returns vague or incomplete results that create more anxiety than clarity. The value comes from matching the right test to the right situation.
What Genetic Testing Actually Does
Genetic testing isn’t one thing. It’s a broad category that covers very different tests with very different purposes. Understanding which type applies to your situation is the first step in deciding whether it’s worthwhile.
Diagnostic testing helps confirm or rule out a suspected genetic condition when you already have symptoms. If your doctor suspects cystic fibrosis or Huntington’s disease, for example, a genetic test can provide a definitive answer.
Predictive testing estimates your risk of developing a condition before symptoms appear. This is the type people think of when they imagine learning whether they’ll get cancer or Alzheimer’s. It can reveal elevated risk for certain types of colorectal cancer, breast cancer, or other hereditary conditions.
Carrier testing tells you whether you carry a gene change that could be passed to your children, even if you’ll never develop the condition yourself. Modern expanded carrier screening panels can analyze up to 110 genes or more, covering dozens or hundreds of recessive conditions at once. This is most useful before or during early pregnancy.
Pharmacogenetic testing identifies how your body processes specific medications. The FDA maintains a list of drug-gene pairs where your genetics directly affect whether a medication is safe or effective for you. For instance, people with a specific gene variant should never take abacavir (an HIV drug) because it triggers severe hypersensitivity reactions. Genetic variations also affect how your body handles warfarin, the blood thinner, and clopidogrel, a common heart medication. For codeine, people who metabolize the drug ultrarapidly face life-threatening respiratory depression. These aren’t theoretical risks; they’re well-established, clinically actionable findings.
Where Testing Delivers Clear Benefits
The strongest case for genetic testing exists when results lead to a specific medical action. BRCA1 and BRCA2 gene mutations offer a clear example. Without any intervention, a BRCA1 mutation carrier has roughly a 53% chance of surviving to age 70. With a combination of screening and preventive surgery, that number improves substantially, with most deaths shifting from cancer-related causes to ordinary causes of mortality. Among BRCA2 carriers, survival to age 70 without intervention is about 71%, and screening alone raises that to 75%.
These numbers matter because they represent real decisions people can make: more frequent cancer screenings starting at younger ages, preventive surgeries, or closer monitoring. The testing itself doesn’t save your life. What saves your life is acting on the information.
Carrier testing before pregnancy is another area where results directly shape decisions. In one study of couples who learned through expanded carrier screening that they both carried genes for the same condition, 62% chose to pursue IVF with preimplantation genetic testing or prenatal diagnosis for future pregnancies. About 29% decided not to change their plans. The point is that the information gave them a choice they wouldn’t have had otherwise.
Consumer Tests vs. Clinical Tests
The distinction between direct-to-consumer kits (like 23andMe) and clinical genetic testing ordered by a doctor is one of the most misunderstood aspects of genetic testing. They are not equivalent.
Consumer tests use a method called genotyping, which checks for specific, pre-selected gene variants. The problem is that these tests often check only a tiny fraction of relevant variants. The 23andMe BRCA test, for example, screens for just 3 variants out of more than 1,000 known BRCA1 and BRCA2 variants associated with increased cancer risk. A negative result on that test does not mean you don’t carry a harmful BRCA mutation. It means you don’t carry those specific three.
Clinical tests ordered through a healthcare provider typically use broader sequencing methods, are performed in certified laboratories, and come with professional interpretation. They also cost more. Direct-to-consumer tests range from under a hundred dollars to several thousand, depending on scope. Consumer health tests are generally not covered by insurance because they aren’t considered diagnostic. Clinical genetic testing ordered by a physician, particularly when there’s a family history or medical indication, is more likely to be covered, though policies vary widely.
The Problem of Uncertain Results
Not every genetic test returns a clean positive or negative. A common outcome, especially with multi-gene panels, is a “variant of uncertain significance,” or VUS. This means the lab found a genetic change, but current science can’t determine whether it actually increases disease risk.
A VUS creates a difficult middle ground. It can’t be used to predict whether you or your family members will develop a condition. Treating it as a positive result could lead to unnecessary worry or even unneeded procedures. Dismissing it entirely could mean missing something important. The standard recommendation is to avoid making medical decisions based on a VUS and to revisit the result periodically, since variants are sometimes reclassified as scientists learn more. But living with that ambiguity is easier said than done.
The more genes a test covers, the more likely you are to receive at least one VUS. This is one reason broader isn’t always better when it comes to choosing a test panel.
Emotional Effects Are Real but Often Manageable
A common concern about genetic testing is that results will cause lasting psychological harm. The research on this is more reassuring than most people expect. Multiple studies have found that the psychological impact of genetic test results, whether positive or negative, is generally modest. One study of breast and ovarian cancer patients found that the presence of a BRCA mutation did not significantly affect anxiety or depression levels compared to those who tested negative.
That said, the testing process itself can be stressful, and the distress isn’t always tied to the result. Having a prior cancer diagnosis, a strong family history of cancer, or young children at home all predicted higher psychological impact regardless of what the test showed. In studies of breast cancer patients undergoing genetic counseling, 20% to 42% were found to need psychological support during the process. The takeaway isn’t that testing is emotionally harmless. It’s that the emotional weight often comes from the situation you’re already in, not from the test result itself.
Privacy and Legal Protections
In the United States, the Genetic Information Nondiscrimination Act (GINA) provides two main protections. Title I prevents health insurers from using genetic information to deny coverage or set premiums. Title II, enforced by the EEOC since 2009, makes it illegal for employers to use genetic information in hiring, firing, promotions, pay, or any other employment decision. Employers are also restricted from requesting or purchasing your genetic information.
The significant gap in GINA is what it doesn’t cover. Life insurance, disability insurance, and long-term care insurance companies are not bound by these protections. They can legally ask about and use genetic test results when making coverage decisions. If you’re considering purchasing any of these policies, it may be worth doing so before undergoing genetic testing, since results become part of your medical record once a clinical test is ordered.
Making the Decision
Genetic testing tends to be most valuable when three conditions are met: there’s a specific question to answer (not just curiosity), the test is comprehensive enough to answer it reliably, and the results would change what you or your doctor actually do. A person with a strong family history of breast cancer getting clinical BRCA testing meets all three criteria. Someone buying a consumer spit kit to “see what’s in there” often meets none of them.
If you have a family history of a genetic condition, are planning a pregnancy with a partner who shares a similar ethnic background or family history, or are starting a medication with known genetic interactions, testing is likely to return information you can use. If you’re healthy with no family history and no specific concern, the calculus is less clear. You’re more likely to encounter uncertain results, and you may end up with information that sounds alarming but isn’t actionable. The question isn’t really whether genetic testing is a good idea in the abstract. It’s whether the specific test you’re considering will tell you something that changes your next step.